Cargando…
(Oral) enoximone in asthma
PDE-3 inhibitors appear to have a large therapeutic value in asthma treatment; this letter provides some of the insights acquired in recent research https://bit.ly/33D9Dgd
Autor principal: | Beute, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682675/ https://www.ncbi.nlm.nih.gov/pubmed/33263042 http://dx.doi.org/10.1183/23120541.00319-2020 |
Ejemplares similares
-
Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children
por: Beute, Jan, et al.
Publicado: (2022) -
Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report
por: Beute, Jan, et al.
Publicado: (2021) -
Enoximone in status asthmaticus
por: Schulz, Oscar, et al.
Publicado: (2020) -
Combined verapamil and atenolol poisoning: resolution of cardiogenic shock with enoximone
por: Gallizzi, F, et al.
Publicado: (2001) -
Influence of enoximone and dobutamine upon liver perfusion and function in fluid optimized septic patients
por: Kern, H, et al.
Publicado: (2000)